Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
Assessment of Pain in Transfusion Dependent Patients With Thalassemia During Transfusion Cycles
2 other identifiers
observational
32
2 countries
9
Brief Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2009
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2009
CompletedFirst Posted
Study publicly available on registry
March 31, 2009
CompletedStudy Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedResults Posted
Study results publicly available
August 27, 2014
CompletedOctober 7, 2015
April 1, 2012
1.3 years
March 30, 2009
April 9, 2014
October 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Report of Pain by Age Group
Subjects reported whether or not they had pain (yes/no) during each transfusion cycle (data on up to 3 transfusion cycles were collected for each subject). The percent of subject-cycles with pain was calculated for the quartiles of the transfusion cycle.
measured daily over the 3 transfusion cycles
Secondary Outcomes (1)
Report of Pain by Length of the Transfusion Cycle
measured daily over the 3 transfusion cycles
Study Arms (2)
age 18-29
People age groups 18-29 with transfusion-dependent thalassemia who have reported at least mild degrees of pain during the main Assessment of Pain study.
age 30+
People age groups 30+ years with transfusion-dependent thalassemia who have reported at least mild degrees of pain during the main Assessment of Pain study.
Eligibility Criteria
People with transfusion-dependent thalassemia who receive care at sites funded by the Thalassemia Clinical Research Network and their satellites.
You may qualify if:
- Participating in the Thalassemia Clinical Research Network Assessment of Pain study
- Has a transfusion dependence of at least eight transfusions per year
- Diagnosis of beta thalassemia or E-beta-thalassemia
- Experiences at least "mild" pain in the 1 month before study entry, as measured by the response to the Brief Pain Inventory (BPI) question #6 from the Assessment of Pain study
You may not qualify if:
- Unwillingness or inability to complete the Brief Pain Inventory Short Form (BPI-SF) on a daily basis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
Children's Hospital Research Center Oakland
Oakland, California, 94609, United States
Stanford University - School of Medicine
Stanford, California, 94305, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30342, United States
Children's Memorial Hospital - Chicago
Chicago, Illinois, 60614, United States
Weill Medical College of Cornell
New York, New York, 10065, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
University Health Network - Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Eric Gerstenberger
- Organization
- New England Research Institutes, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Dru Foote, NP
Children's Hospital and Research Institute Oakland
- STUDY CHAIR
Jeanne Boudreaux, MD
Children's Healthcare of Atlanta
- STUDY CHAIR
Thomas Coates, MD
Children's Hospital Los Angeles
- STUDY CHAIR
Elliott Vichinsky, MD
UCSF Benioff Children's Hospital Oakland
- STUDY CHAIR
Michael Jeng, MD
Stanford University
- STUDY CHAIR
Janet Kwiatkowski, MD
Children's Hospital of Philadelphia
- STUDY CHAIR
Nancy Olivieri, MD
University Health Network - Toronto General Hospital
- STUDY CHAIR
Patricia J. Giardina, MD
Weill Medical College of Cornell
- STUDY CHAIR
Brigitta Mueller, MD
Baylor College of Medicine
- STUDY CHAIR
Alexis A. Thompson, MD, MPH
Ann & Robert H Lurie Children's Hospital of Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2009
First Posted
March 31, 2009
Study Start
July 1, 2009
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
October 7, 2015
Results First Posted
August 27, 2014
Record last verified: 2012-04